Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

Clinical trial NCT01505647 · COMPLETED

Trial details

NCT number: NCT01505647
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Herpes Zoster Shingles

Start date: 2012-04-01
Primary completion: 2012-07-01
Enrollment: 498

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.